SDF2

SDF2 is a constitutively ER-resident protein that functions as an essential co-factor of the DNAJB11 (ERdj3)–BiP chaperone system, where it suppresses aggregation of misfolded ER cargo (PMID:28597544). SDF2 forms a stable complex with the ERdj3 (DNAJB11/HSP40) dimer, with two SDF2/SDF2L1 molecules replacing an ERdj3 homotetramer; this complex retains ERdj3 in the ER and possesses higher chaperone activity than ERdj3 alone, suppressing protein aggregation independently of substrate transfer to BiP (PMID:31624144). SDF2 and SDF2L1 act as essential subunits of the DNAJB11 complex required for normal processing of Polycystin-1, and their abundance is reciprocally interdependent with that of DNAJB11 (PMID:41109348). Beyond its chaperone role, SDF2 suppresses GRP78-mediated ER-associated degradation of the copper transporters ATP7A and ATP7B (PMID:40709395). The protein adopts a β-trefoil fold containing three MIR motifs (PMID:24878610).

1. 1996 Medium

   Established SDF2 as a discrete secretory gene product, providing the molecular entry point before any function was known.

   Evidence Signal sequence trap cloning, sequence analysis, and chromosomal mapping of human SDF2

   PMID:8918255

   Open questions at the time

   • Functional role inferred only by sequence similarity to yeast mannosyltransferases
   • No enzymatic activity tested
   • Localization not directly demonstrated
2. 2014 Low

   Defined SDF2's subcellular compartment and structural architecture, anchoring it as an ER protein with a defined fold rather than a secreted enzyme.

   Evidence Immunofluorescence/fractionation localization and homology-based 3D structure prediction of mouse Sdf2

   PMID:24878610

   Open questions at the time

   • Structure is predicted/homology-modeled, not experimentally solved
   • No functional mechanism tested
   • Binding partners unidentified
3. 2017 High

   Resolved SDF2's molecular function by placing it in the BiP chaperone cycle as a stable ERdj3 partner that prevents misfolded cargo aggregation.

   Evidence Reciprocal Co-IP, in vitro aggregation suppression assay, and dominant-negative ERdj3 mutant in cells

   PMID:28597544

   Open questions at the time

   • Complex stoichiometry not yet defined
   • Specific physiological substrates unknown
   • Relationship to SDF2L1 unresolved
4. 2019 High

   Defined the architecture and biochemical logic of the complex, showing SDF2/SDF2L1 reorganize ERdj3 oligomerization and confer enhanced chaperone activity that does not require substrate handoff to BiP.

   Evidence In vitro Co-IP and aggregation assays with denatured substrate, size-exclusion stoichiometry, and in cellulo localization/chaperone assays

   PMID:31624144

   Open questions at the time

   • Native substrate repertoire not catalogued
   • Structural basis of the 2:2 complex not crystallographically resolved
   • Functional distinction between SDF2 and SDF2L1 unclear
5. 2025 High

   Connected the chaperone complex to a defined physiological client, establishing SDF2/SDF2L1 as required subunits for Polycystin-1 processing with reciprocal abundance control over DNAJB11.

   Evidence Unbiased DNAJB11 interaction proteomics, SDF2/SDF2L1 double-knockout cell lines, rescue, and PC1 processing assay

   PMID:41109348

   Open questions at the time

   • Direct disease link to SDF2 mutation not established
   • Mechanism of reciprocal abundance regulation unknown
   • Other physiological clients not mapped
6. 2025 Medium

   Identified a distinct ERAD-regulatory role, showing SDF2 normally restrains GRP78-mediated degradation of copper transporters ATP7A/ATP7B.

   Evidence shRNA knockdown, MG132 and GRP78 silencing, and in vivo tumor model with GRP78 overexpression rescue in glioma cells

   PMID:40709395

   Open questions at the time

   • No in vitro reconstitution of the SDF2–GRP78–ATP7A/B axis
   • Single lab and cell context (glioma)
   • Mechanistic link between SDF2 loss and GRP78 induction undefined
7. 2025 Low

   Placed SDF2 downstream of a microRNA and implicated it in proliferation/differentiation signaling, extending its biology beyond ER chaperone function.

   Evidence Dual-luciferase reporter, SDF2 overexpression, proliferation/migration assays, and JAK2/STAT3 phosphorylation Western blots in UCB-MSCs

   PMID:41184975

   Open questions at the time

   • JAK2/STAT3 link is indirect and not mechanistically connected to ER function
   • Single study, single cell type
   • No demonstration that ER-resident SDF2 mediates the signaling effect

• How SDF2's ER chaperone role mechanistically relates to its reported regulation of ERAD and to broader cell signaling outputs remains unresolved.
• No experimentally solved structure of the human ERdj3–SDF2 complex
• Full client substrate spectrum uncharacterized
• Unclear whether ERAD and signaling phenotypes derive from the chaperone activity